Prior to infection with L. major, we ceased treatment with anti-CD8 antibodies and at 4 weeks post L. major infection the circulating levels of CD8 T cells in LCMV immune CD8 depleted mice had recovered to levels comparable with L. major infected non-depleted mice (Figure 6B). This evidence concerns the gene CD8A and infection.